IVIG may be worthwhile in treatment of refractory active diffuse scleroderma

Intravenous immunoglobulin may be an effective add-on therapy for patients with active diffuse cutaneous systemic sclerosis who are unresponsive to traditional immunosuppressive treatment, a...